Wee Leng Lee

1.4k total citations · 1 hit paper
14 papers, 832 citations indexed

About

Wee Leng Lee is a scholar working on Pharmacology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Wee Leng Lee has authored 14 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 4 papers in Infectious Diseases and 4 papers in Pharmacology. Recurrent topics in Wee Leng Lee's work include Eicosanoids and Hypertension Pharmacology (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Antibiotic Resistance in Bacteria (3 papers). Wee Leng Lee is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Antibiotic Resistance in Bacteria (3 papers). Wee Leng Lee collaborates with scholars based in Australia, Malaysia and Spain. Wee Leng Lee's co-authors include David C. M. Kong, Wirawan Jeong, Caitlin Keighley, Rory Wolfe, Monica A. Slavin, S.C.-A. Chen, Lay Kek Teh, Rusli Ismail, Yee Chang Soh and Ken Lee Chin and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Clinica Chimica Acta.

In The Last Decade

Wee Leng Lee

14 papers receiving 807 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports

2018 604 citations Wirawan Jeong, Caitlin Keighley et al. Clinical Microbiology and Infection profile →

Peers

Wee Leng Lee

EPIDE

PHARM

OTORH

PHARM

Shariq Haider Canada

P. Lutun France

Yukihiro Hamada Japan

Goran Stevanović Serbia

Fedja Farowski Germany

Ben E. dePauw Netherlands

Tiphaine Gaillard France

F. Scaglione Italy

Jerry M. Zuckerman United States

Shariq Haider Canada

Wee Leng Lee

479 ×0.8

456 ×1.2

EPIDE

79 ×0.8

PHARM

5 ×0.1

OTORH

16 ×0.2

PHARM

Citations per year, relative to Wee Leng Lee Wee Leng Lee (= 1×) peers Shariq Haider

Countries citing papers authored by Wee Leng Lee

Since Specialization

Citations

This map shows the geographic impact of Wee Leng Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wee Leng Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wee Leng Lee more than expected).

Fields of papers citing papers by Wee Leng Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wee Leng Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wee Leng Lee. The network helps show where Wee Leng Lee may publish in the future.

Co-authorship network of co-authors of Wee Leng Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Wee Leng Lee. A scholar is included among the top collaborators of Wee Leng Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wee Leng Lee. Wee Leng Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Cortés-Lara, Sara, Kate E. Rogers, Carla López-Causapé, et al.. (2024). The effects of single and multiple resistance mechanisms on bacterial response to meropenem. Clinical Microbiology and Infection. 30(10). 1276–1283. 1 indexed citations

Agyeman, Akosua Adom, Carla López-Causapé, Kate E. Rogers, et al.. (2023). Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activity. International Journal of Antimicrobial Agents. 62(3). 106887–106887. 10 indexed citations

Harper, Marina, Sara Cortés-Lara, Kate E. Rogers, et al.. (2023). Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and Heteroresistance. Antimicrobial Agents and Chemotherapy. 67(8). e0041423–e0041423. 4 indexed citations

Landersdorfer, Cornelia B., Wee Leng Lee, Roger L. Nation, et al.. (2022). Penetration of Vancomycin into Noninfected Bone in Patients Undergoing Total Joint Arthroplasty Evaluated by a Minimal Physiologically Based Population Pharmacokinetic Modeling Approach. Molecular Pharmaceutics. 20(3). 1509–1518. 1 indexed citations

Barnett, Timothy C., Kate E. Rogers, Wee Leng Lee, et al.. (2022). Penicillin G concentrations required for prophylaxis against Group A Streptococcus infection evaluated using a hollow fibre model and mathematical modelling. Journal of Antimicrobial Chemotherapy. 77(7). 1923–1930. 1 indexed citations

Jeong, Wirawan, Caitlin Keighley, Rory Wolfe, et al.. (2019). Contemporary management and clinical outcomes of mucormycosis: A systematic review and meta-analysis of case reports. International Journal of Antimicrobial Agents. 53(5). 589–597. 67 indexed citations

Jeong, Wirawan, Caitlin Keighley, Rory Wolfe, et al.. (2018). The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clinical Microbiology and Infection. 25(1). 26–34. 604 indexed citations breakdown →

Chin, Ken Lee, et al.. (2014). Comparing Effectiveness of High-Fidelity Human Patient Simulation vs Case-Based Learning in Pharmacy Education. American Journal of Pharmaceutical Education. 78(8). 153–153. 40 indexed citations

Teh, Lay Kek, et al.. (2009). CYP2C9 polymorphism: prevalence in healthy and warfarin-treated Malay and Chinese in Malaysia.. PubMed. 50(5). 490–3. 23 indexed citations

10.

Teh, Lay Kek, et al.. (2008). Role of pharmacodiagnostic of CYP2C9 variants in the optimization of warfarin therapy in Malaysia: A 6-month follow-up study. Xenobiotica. 38(6). 641–651. 14 indexed citations

11.

Teh, Lay Kek, et al.. (2007). Single step PCR for detection of allelic variation of MDR1 gene (P-glycoprotein) among three ethnic groups in Malaysia. Journal of Clinical Pharmacy and Therapeutics. 32(3). 313–319. 19 indexed citations

12.

Lee, Wee Leng, et al.. (2005). Genetic polymorphism of CYP2C8 in three Malaysian ethnics: CYP2C8*2 and CYP2C8*3 are found in Malaysian Indians. Journal of Clinical Pharmacy and Therapeutics. 30(5). 487–490. 26 indexed citations

13.

Lee, Wee Leng, et al.. (2004). A simple multiplex PCR method for the concurrent detection of three CYP2C8 variants. Clinica Chimica Acta. 349(1-2). 191–198. 9 indexed citations

14.

Wang, Jinn‐Chyi, et al.. (2001). Antimutagenicity of extracts of Hericium erinaceus.. PubMed. 17(5). 230–8. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact